Claire Thompson
Founder and CEO
Harlow, England, United Kingdom
Professional Overview
Claire Thompson is an accomplished entrepreneur and industry leader in the life sciences sector. As the Founder and CEO of Agility Life Sciences, she leverages over 15 years of experience in pharmaceutical research and development to drive innovation and business growth. Recognized for her expertise in biotechnology and drug discovery, Claire also serves as an Honorary Professor at the University of Nottingham and Entrepreneur in Residence at the University of Cambridge.
Experience Summary
Current Role
As the Founder and CEO of Agility Life Sciences since 2012, Claire is responsible for setting the strategic vision and overseeing all aspects of the company's operations. Under her leadership, Agility has emerged as a leading contract research organization, supporting cutting-edge drug discovery and development projects for clients worldwide. Claire's entrepreneurial acumen and deep technical knowledge have been instrumental in securing strategic partnerships, expanding the company's service offerings, and fostering a culture of innovation.
Career Progression
Prior to founding Agility Life Sciences, Claire held various academic and research positions, including Honorary Senior Lecturer at University College London and Deputy Chief Scientist at the Royal Pharmaceutical Society. These roles allowed her to cultivate an extensive network within the life sciences community and gain valuable insights into the industry's evolving needs and challenges.
Academic Background
Claire holds a Ph.D. in Pharmaceutical Sciences from the University of Cambridge, where her research focused on the development of novel drug delivery systems. Her academic achievements and research contributions have been recognized through numerous awards and publications in peer-reviewed journals.
Areas of Expertise
- Biotechnology and drug discovery
- Pharmaceutical research and development
- Contract research and outsourcing services
- Entrepreneurship and business strategy
- Academic-industry collaboration
Professional Impact
Under Claire's leadership, Agility Life Sciences has become a trusted partner for pharmaceutical and biotechnology companies, delivering high-quality research and development services that have accelerated the progress of several promising drug candidates. Claire's commitment to fostering industry-academia partnerships has also led to the successful translation of cutting-edge research into commercial applications, benefiting patients and advancing the field of life sciences.
Conclusion
With a proven track record of entrepreneurial success and a deep understanding of the life sciences industry, Claire Thompson is well-positioned to continue driving Agility Life Sciences' growth and impact. Her multifaceted expertise, combined with her dedication to innovation and collaboration, make her a valuable asset in the ever-evolving landscape of pharmaceutical research and development.
